First etanercept biosimilar approved in the European Union
Biogen will manufacture and commercialize BENEPALI® in the EU
19-Jan-2016 -
The joint venture between Biogen and Samsung BioLogics, Samsung Bioepis, has been granted European Commission (EC) approval for BENEPALI ® , an etanercept biosimilar referencing Enbrel ®. BENEPALI has been granted marketing authorization in the European Union (EU) for the treatment of adults with ...
axial spondyloarthritis
Biogen
etanercept
+2